Pulse Biosciences
PLSE
29 hedge funds and large institutions have $6.43M invested in Pulse Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
211% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $475K
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
22% more capital invested
Capital invested by funds: $5.28M → $6.43M (+$1.15M)
0.03% more ownership
Funds ownership: 6.58% → 6.61% (+0.03%)
6% less funds holding
Funds holding: 31 → 29 (-2)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Griffin Asset Management
New York
|
+$202K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$55.2K |
| 3 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$48.3K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$40.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$39.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
E
Ergoteles
New York
|
-$85K |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$56.4K |
| 3 |
Millennium Management
New York
|
-$30.6K |
| 4 |
AGM
Alpine Global Management
New York
|
-$28K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SPIA
26
Steward Partners Investment Advisory
New York
| $493 | – | – | – |
|
|
WIM
27
Westside Investment Management
Santa Monica,
California
| $383 | -$13.7K | -6,114 | -4% |
|
|
E
28
Ergoteles
New York
| – | -$85K | -37,096 | Closed |
|
|
AGM
29
Alpine Global Management
New York
| – | -$28K | -12,274 | Closed |
|
|
BFM
30
Boothbay Fund Management
New York
| – | -$28K | -12,274 | Closed |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$27K | -11,657 | Closed |
|
32
Citigroup
New York
| – | -$10K | -4,500 | Closed |
|
33
Group One Trading
Chicago,
Illinois
| – | -$6.16K | -2,742 | Closed |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| – | +$359 | +160 | New |
|
PLSE Hedge Fund Activity: Q4 2022 in Review
29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2022, worth a combined $6.43M — up 22% from $5.28M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PLSE and 6 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 9 added.
The largest buyer was Griffin Asset Management, adding an estimated $202K. The largest seller was Ergoteles, exiting entirely with an estimated $85K sold.
- 29 institutional investors held Pulse Biosciences (PLSE) as of Q4 2022, down from 31 in Q3 2022.
- Funds reported $6.43M of Pulse Biosciences stock for Q4 2022, up 22% quarter-over-quarter.
- 6 funds opened new Pulse Biosciences positions in Q4 2022 and 7 closed out, a net change of -1 holder.
- The largest Pulse Biosciences buyer in Q4 2022 was Griffin Asset Management, an estimated $202K added.
- The largest Pulse Biosciences seller in Q4 2022 was Ergoteles, an estimated $85K sold.
Based on aggregated 13F filings for Q4 2022.